@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .

nalt:235410
  skos:related nalt:3816, nalt:1318 ;
  skos:altLabel "17 alpha-hydroxyprogesterone capronate"@en, "delalutin"@en, "17-hydroxyprogesterone capronate"@en, "17 alpha-oxyprogesterone capronate"@en, "hydroxyprogesterone hexanoate"@en, "hydroxyprogesterone caproate"@en ;
  skos:hiddenLabel "17-alpha-hydroxyprogesterone-n-caproate"@en, "hydroxyprogesterone-hexanoate"@en, "17-alpha hydroxy progesterone caproate"@en, "17 alpha hydroxy progesterone caproate"@en, "hydroxyprogesterone-caproate"@en, "17-a-hydroxy-progesterone-17-n-caproate"@en, "17-alpha-hydroxy-progesterone-17-n-caproate"@en ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:broader nalt:51990 ;
  a <https://lod.nal.usda.gov/naltv#Topic>, skos:Concept ;
  skos:prefLabel "17 alpha-hydroxyprogesterone caproate"@en, "caproato de 17 alfa-hidroxiprogesterona"@es ;
  dc:created "2015-01-08"^^xsd:date ;
  ns0:marc001 "62277" ;
  dc:modified "2019-12-16"^^xsd:date ;
  skos:definition nalt:235410_def .

nalt:1318
  skos:prefLabel "hidroxiprogesteronas"@es, "hydroxyprogesterones"@en ;
  a ns0:Chemical, skos:Concept ;
  skos:related nalt:235410 .

nalt:3816
  skos:prefLabel "agentes antineoplásicos"@es, "antineoplastic agents"@en ;
  a ns0:Chemical, skos:Concept ;
  skos:related nalt:235410 .

nalt:51990
  skos:prefLabel "progestogenes sintéticos"@es, "synthetic progestogens"@en ;
  a ns0:Topic, skos:Concept ;
  skos:narrower nalt:235410 .

ns0:Topic
  rdfs:label "Topic"@en ;
  a owl:Class .

nalt:235410_def
  rdf:value "Derivado de la hidroxiprogesterona que actúa como una progestina y se usa para reducir el riesgo de aborto espontáneo recurrente y de nacimiento prematuro. Además, combinado con estrógeno, se utiliza en la gestión de trastornos menstruales."@es, "Hydroxyprogesterone derivative that acts as a progestin and is used to reduce the risk of recurrent miscarriage and of premature birth. It is also used in combination with estrogen in the management of menstruation disorders."@en ;
  dc:source "Medical Subject Headings" ;
  a ns0:Definition .

<https://lod.nal.usda.gov/nalt>
  rdfs:label "NALT Full"@en ;
  a skos:ConceptScheme .